BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10080904)

  • 1. Stability of the residual structure in unfolded BPTI in different conditions of temperature and solvent composition measured by disulphide kinetics and double mutant cycle analysis.
    Zdanowski K; Dadlez M
    J Mol Biol; 1999 Mar; 287(2):433-45. PubMed ID: 10080904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic interactions accelerate early stages of the folding of BPTI.
    Dadlez M
    Biochemistry; 1997 Mar; 36(10):2788-97. PubMed ID: 9062106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding.
    Dadlez M; Kim PS
    Biochemistry; 1996 Dec; 35(50):16153-64. PubMed ID: 8973187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates.
    Darby NJ; Morin PE; Talbo G; Creighton TE
    J Mol Biol; 1995 Jun; 249(2):463-77. PubMed ID: 7540214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes.
    Creighton TE; Bagley CJ; Cooper L; Darby NJ; Freedman RB; Kemmink J; Sheikh A
    J Mol Biol; 1993 Aug; 232(4):1176-96. PubMed ID: 7690407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
    Bulaj G; Goldenberg DP
    J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor. Forming the first disulphide bonds in analogues of the reduced protein.
    Darby NJ; Creighton TE
    J Mol Biol; 1993 Aug; 232(3):873-96. PubMed ID: 7689114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
    Kuroda Y; Kim PS
    J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small effects of amino acid replacements on the reduced and unfolded state of pancreatic trypsin inhibitor.
    Goldenberg DP; Zhang JX
    Proteins; 1993 Mar; 15(3):322-9. PubMed ID: 7681211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H NMR analysis of the partly-folded non-native two-disulphide intermediates (30-51,5-14) and (30-51,5-38) in the folding pathway of bovine pancreatic trypsin inhibitor.
    van Mierlo CP; Kemmink J; Neuhaus D; Darby NJ; Creighton TE
    J Mol Biol; 1994 Jan; 235(3):1044-61. PubMed ID: 7507172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
    Kibria FM; Lees WJ
    J Am Chem Soc; 2008 Jan; 130(3):796-7. PubMed ID: 18166059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of a subdomain in the folding of bovine pancreatic trypsin inhibitor.
    Staley JP; Kim PS
    Nature; 1990 Apr; 344(6267):685-8. PubMed ID: 1691452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability.
    Kowalski JM; Parekh RN; Wittrup KD
    Biochemistry; 1998 Feb; 37(5):1264-73. PubMed ID: 9477952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of individual side-chains to the stability of BPTI examined by alanine-scanning mutagenesis.
    Yu MH; Weissman JS; Kim PS
    J Mol Biol; 1995 Jun; 249(2):388-97. PubMed ID: 7540212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phi-values for BPTI folding intermediates and implications for transition state analysis.
    Bulaj G; Goldenberg DP
    Nat Struct Biol; 2001 Apr; 8(4):326-30. PubMed ID: 11276252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements.
    van Mierlo CP; Darby NJ; Keeler J; Neuhaus D; Creighton TE
    J Mol Biol; 1993 Feb; 229(4):1125-46. PubMed ID: 7680380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural stability of disulfide mutants of basic pancreatic trypsin inhibitor: a molecular dynamics study.
    Schiffer CA; van Gunsteren WF
    Proteins; 1996 Sep; 26(1):66-71. PubMed ID: 8880930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.